Á˽âÍòÏó³Ç¹ÙÍø×îÐÂ×ÊѶ
ÅÁ½ðɲ¡£¨PD£©ÊÇÒ»ÖÖÓëÑõ»¯Æ½ºâ¸Ä±äÓйصÄÉñ¾ÏµÍ³¼²²¡£¬ÕâÖÖ¼²²¡×î³£¼ûµÄÁÙ´²ÌåÏÖ°üÀ¨×ÔÖ÷Éñ¾ºÍÔ˶¯¹¦Ð§µÄ½øÐÐÐÔ¶ñ»¯£¬ÔÚijЩÇé¿öÏ£¬»¹°üÀ¨ÈÏÖªÄÜÁ¦Ï½µ¡£
?
ƾ¾Ý×îаæÖйúÅÁ½ðɲ¡ÖÎÁÆÖ¸ÄÏ£¬Î´À´ÎÒ¹úÅÁ½ðɲ¡»¼²¡ÈËÊý½«´Ó2005ÄêµÄ199ÍòÈËÉÏÉýµ½2030ÄêµÄ500ÍòÈË£¬ÏÕЩռµ½È«ÇòÅÁ½ðɲ¡»¼²¡ÈËÊýµÄÒ»°ë¡£
?
?
»¼²¡ÂÊËæÄêÁäÔö³¤£¬60-64 ËêÄêÁä×黼²¡ÂÊΪ0.84% £¬ÔÚ80¡ª84 ËêÄêÁä×éÔö³¤Îª2.37% ¡£µ«ÔÚ85Ëê¼°ÒÔÉÏ×éÖÐÊӲ쵽Çá΢ϽµÖÁ1.86%¡£
?
ÁÙ´²¹ØÓÚÅÁ½ðɲ¡µÄ·¢²¡»úÖÆÖ÷Òª¿´·¨ÊÇÑõ»¯Ó¦¼¤Ôì³É»úÌå·ºÆð´ó×ÚÑõ×ÔÓÉ»ù£¬»¼Õß´óÄÔºÚÖÊÖзºÆðÁËÑõ»¯Ó¦¼¤·´Ó¦£¬µ¼ÖÂÂÑ°×ÖÊÒÔ¼°DNAµÄËðÉË£¬²¢ÇÒÅãͬÌúÀë×ӵľۼ¯ÒÔ¼°Ö¬ÖʹýÑõ»¯·´Ó¦£¬´Ó¶øÓÕ·¢ÁËÏßÁ£Ìå»îÐÔµÄϽµÒÔ¼°¹Èë׸ÊëÄˮƽµÄϽµ¡£Òò´Ë£¬Í¨¹ý¿¹Ñõ»¯ÖÎÁÆÔڸò¡µÄÁÙ´²ÖÎÁÆÖÐÄܹ»Æ𵽽Ϻõı£»¤Éñ¾µÄЧ¹û¡£
?
¹Èë׸ÊëÄ£¨GSH£©ÊÇ´óÄÔÖб£´æÊýÁ¿×î¶àµÄ¿ÉÈÜÐÔ¿¹Ñõ»¯·Ö×Ó£¬¿ÉÒÔͨ¹ý¼õÉÙ»îÐÔÑõÀ´±£»¤»úÌåÃâÊÜÑõ»¯Ó¦¼¤ÓÕµ¼µÄËðÉË£¬ÔÚ´óÄÔÖÐÖ÷ÒªÂþÑÜÓÚÉñ¾Ôª¡¢½ºÖÊϸ°ûÖУ¬¾ßÓÐÖØÒªµÄ½â¶¾¼°¿¹Ñõ»¯×÷Óá£
?
?
´óÄÔÖеĹÈë׸ÊëÄÖ÷ÒªÔÚÐÇÐνºÖÊϸ°û(ÂÌÉ«)ºÍ¶à°Í°·ÄÜÉñ¾Ôª(À¶É«)¼äºÏ³É£¬¹Èë׸ÊëÄÊÇÓɦÃ-¹È°±õ£°ëë×°±ËáÁ¬½Óø(GCL)ºÍ¹Èë׸ÊëĺϳÉøÌí¼Ó¸Ê°±ËáºÏ³ÉµÄ¡£Ò»µ©Éú³É£¬Ñõ»¯ÐÎʽµÄ¹Èë׸ÊëÄ(GSSG)¿ÉÒÔͨ¹ý¹Èë׸ÊëÄ»¹Ôø(GR)ºÍNADPHÑ»·Îª»¹ÔÐ͹Èë׸ÊëÄ¡£
Ïà¹ØµÄ¹Èë׸ÊëÄ¿¹Ñõ»¯Ê¾Òâͼ
?
¹Èë׸ÊëĵļõÉÙ¹ØÓÚ¶à°Í°·Éñ¾ÔªµÄ´æ»îÓÐÒ»¶¨µÄÓ°Ï죬ÓÉÓÚÑõ»¯Ó¦¼¤·´Ó¦Ðγɴó×ڵĻîÐÔÑõ·Ö×Ó£¬¿Éµ¼ÖÂÄÔϸ°ûµòÍöËٶȼÓËÙ¡£ »Ö¸´ÅÁ½ðɲ¡»¼Õß´óÄÔÖйÈë׸ÊëĵÄˮƽ¿ÉÄÜÊÇÒ»ÖÖÓÐÏ£ÍûµÄÖÎÁÆÒªÁ죬¿ÉÒÔ±£»¤ÊÜËðµÄ¶à°Í°·ÄÜÉñ¾ÔªÃâÊܽøÒ»²½ËðÉË¡£
?
¹Èë׸ÊëÄÊÇÒ»ÖÖ¸ßЧµÄÄÔÉñ¾±£»¤¼Á£¬Äܹ»ÓÐЧÖÆÖ¹¹ýÑõ»¯¶ÔÄÔϸ°ûÔì³ÉµÄËðÉË£¬´Ó¶ø¸ÄÉÆÄÔÉñ¾ÔªËðʧ֢״£¬½µµÍÓÉÓÚ¶à°Í°·Ï½µÒýÆðµÄÉñ¾ÔªËðÉË£¬ÔÚÅÁ½ðɲ¡ÖоßÓнϺõÄÓ¦ÓÃЧ¹û¡£
?
?
²Î¿¼ÎÄÏ×£º
1¡¢ÖйúÅÁ½ðɲ¡ÖÎÁÆÖ¸ÄÏ£¨µÚËİ棩
2¡¢°üºì.»¹ÔÐ͹Èë׸ÊëÄÖÎÁÆÅÁ½ðɲ¡µÄÁÙ´²Ð§¹ûÊÓ²ì[J].ÁÙ´²ºÏÀíÓÃÒ©,2018,11(7):44-45.
3¡¢Smeyne M,et al.Glutathione Metabolism and Parkinson¡¯s Disease.Free Radic Biol Med. 2013 Sep;62:13¨C25.
4¡¢Bharath S,et al.Glutathione,iron and Parkinson's disease.Biochem Pharmacol.2002 Sep;64(5-6):1037-48.
5¡¢ Qi S,et al. Prevalence of Parkinson's Disease: A Community-Based Study in China.Mov Disord. 2021 Aug 14.
Copyright ? YAOPHARMA All Rights Reserved¡¡¡¡
ÓåICP±¸11001460ºÅ-1
Ó幫Íø°²±¸ 50019002502150